Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF) is a leader in cannabinoid-derived drug discovery and development. The company announces that it has initiated the in-life phase of the clinical trial operations now that the investigational QIXLEEF™ drug has been shipped by Aphria […]





